The hemolytic uremic syndrome (HUS) is a life-threatening disease of the kidney that is induced by shiga toxin-producing E.coli. Major changes in the monocytic compartment and in CCR2-binding chemokines have been observed. However, the specific contribution of CCR2-dependent Gr1 high monocytes is unknown. To investigate the impact of these monocytes during HUS, we injected a combination of LPS and shiga toxin into mice. We observed an impaired kidney function and elevated levels of the CCR2-binding chemokine CCL2 after shiga toxin/LPS-injection, thus suggesting Gr1 high monocyte infiltration into the kidney. Indeed, the number of Gr1 high monocytes was strongly increased one day after HUS induction. Moreover, these cells expressed high levels of CD11b suggesting activation after tissue entry. Non-invasive PET-MR imaging revealed kidney injury mainly in the kidney cortex and this damage coincided with the detection of Gr1 high monocytes. Lack of Gr1 high monocytes in Ccr2-deficient animals reduced neutrophil gelatinase-associated lipocalin and blood urea nitrogen levels. Moreover, the survival of Ccr2-deficient animals was significantly improved. Conclusively, this study demonstrates that CCR2-dependent Gr1 high monocytes contribute to the kidney injury during HUS and targeting these cells is beneficial during this disease.
Introduction
Shiga-toxin (Stx) -producing enterohaemorrhagic E.coli (STECs) have been implicated in serious outbreaks of the hemolytic uremic syndrome (HUS), a life-threatening disease characterized by microangiopathic haemolytic anaemia, thrombocytopenia and acute kidney injury [1] . In this disease, Stx traverses the intestinal epithelium and binds to the glycolipid globotriaosylceramide (Gb3) on endothelial cells causing severe vascular damage [2] . The animal model that mimics STEC-HUS is induced by the injection of LPS and Stx into mice [3] [4] [5] [6] . Since Gb3 is highly expressed in the renal microvasculature, the Stx-dependent endothelial damage causes acute kidney injury and reduces the glomerular filtration capacity [7, 8] . Among other, damage to the renal endothelium is characterized by increased serum levels of blood urea nitrogen (BUN) [8, 9] . Moreover, endothelial damage induces binding of platelets to exposed subendothelial collagen, which further induces the recruitment of leukocytes to the site of vascular injury [10] . Moreover, neutrophil gelatinase-associated lipocalin (NGAL) is a transient tubular damage marker that indicates injury of proximal tubular epithelial cells. However, a therapy against this severe disease is still elusive, thus further interventional studies are required to delineate the mechanism relevant during HUS.
The kidney harbors a dense network of myeloid cells, such as macrophages and dendritic cells [11, 12] . In homeostatic and inflammatory conditions, these cells are present throughout the interstitial and mesangial spaces of the entire kidney [11] . Macrophages have been shown to undergo local proliferation during inflammation in the kidney [13] . Moreover, monocytes have been shown to differentiate into macrophages after leaving the blood stream and entering the kidney [14] . Two subsets of blood monocytes have been identified previously, which can be subdivided by their differential expression of the surface molecule Gr1 and the chemokine receptor CCR2 [15, 16] . During HUS, there is evidence for increased expression of monocyte-recruiting chemokines, such as CCL2, CCL3 and CCL5 and upregulation of the corresponding receptors, namely CCR1, CCR2 and CCR5 has been shown [5, [17] [18] [19] . Major changes in the composition of monocytes in the blood has been observed during HUS and histological studies of HUS biopsy specimens showed the presence of monocytes in the glomeruli [18, 20] . These data suggest an important role of chemokine-dependent recruitment of monocytes during HUS. In this study, we have investigated the specific contribution of Gr1 high monocytes during HUS by employing mice deficient for CCR2.
Results

Acute kidney injury is associated with increased chemokine expression
To investigate the kidney damage in mice after inducing HUS, we intravenously injected a combination of Stx and LPS into mice and assessed the level of kidney function by measuring blood urea nitrogen (BUN). We observed elevated levels of BUN in the serum (Fig. 1A) , increased expression of the kidney injury marker-1 (KIM-1) (Fig. 1B) and elevated tubular expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney of these mice (Fig. 1C) , thereby indicating acute kidney injury. Next, we analyzed the levels of the monocyte-recruiting chemokines CCL2, CCL3, CCL4 and CCL5 in the supernatant of homogenized kidneys. We detected elevated levels of these chemokines in kidney homogenates of Stx/LPS-treated mice (Fig. 2) Fig. 3A ), whereas CD45.1 + Gr1 low macrophages were barely detectable on day 1 and day 3 (Supporting Information Fig. 3B ). These data suggest that the increase of Gr1 low macrophages on day 3 might be due to other mechanisms beyond differentiation of Gr1 high monocytes. To further investigate whether the return of Gr1 low macrophages on day 3 can also be explained by self-renewal, we analyzed the incorporation of BrdU during the course of the disease. We found that some Gr1 low macrophages incorporated BrdU on day 3 demonstrating their proliferative capacity after Stx/LPS injection (Supporting Information Fig. 3C ).
Non-invasive in vivo imaging and microscopy reveal kidney injury and Gr1 high monocytes in the cortex
We then localized the kidney injury and Gr1 high monocytes in the kidney by non-invasive in vivo imaging and microscopy. We employed positron emission tomography (PET) and co-registered magnet resonance (MR) images after injection of [ 64 Cu]NOTAglycoprotein VI (GPVI)-Fc tracer [21, 22 ] to detect exposed subendothelial collagen after endothelial injury in the kidney. We found enhanced uptake of this tracer in the kidney after Stx/LPS injection ( Fig. 4A and B) demonstrating endothelial damage and identifying a novel non-invasive imaging technique to score endothelial kidney injury during HUS. We also observed accumulation of the tracer in the liver, which is a common phenomenon for 64 Cu-labelled tracers due to the trans-chelation of copper to liver enzymes [23] . Ex vivo autoradiography revealed a strong tracersignal in the cortex of Stx/LPS injected animals ( Fig. 4A , lower right image). To analyze whether this accumulation of the tracer in the cortex is associated with the infiltration of Gr1 high monocytes on day 1 post Stx/LPS injection, we localized these cells in the kidney by histology. We found numerous Gr1 high monocytes particularly in the renal cortex ( Fig. 5A and B), thereby suggesting that the appearance of Gr1 high monocytes in the renal cortex may cause the kidney injury.
Targeting CCR2-dependent Gr1 high monocytes ameliorates kidney injury
To investigate whether Gr1 high monocytes contribute to the development of HUS, we assessed the proinflammatory cytokine milieu in the kidney, the kidney damage by measuring BUN, the survival and the expression of NGALs, in Ccr2-deficient mice. We found reduced abundance of Gr1 high monocytes in the kidney in Ccr2-deficient mice, whereas Gr1 low macrophages were unchanged ( in Ccr2-deficient animals significantly reduced the BUN levels in the serum (Fig. 6B ) and the survival was significantly improved (Fig. 6C ). Although only slightly increased in comparison to the healthy controls, we found that IL-1b and IL-6 were significantly decreased on day 3 (Supporting Information Fig. 4 ) indicating that the inflammatory response might be ameliorated in the absence of Gr1 high monocytes between day 1 and day 3. Moreover, we detected reduced expression of NGAL on day 1 (Fig. 6D ). These data demonstrate that CCR2-dependent Gr1 high monocytes are critical for the development of HUS.
Discussion
Monocytes are critical inducers of kidney diseases and targeting the recruitment of these cells prevents inflammation and disease induction [12, [24] [25] [26] . The recruitment of monocytes is mediated by chemokines and their receptors and targeting these molecules has been shown beneficial against inflammation and disease progression [25, [27] [28] [29] [30] [31] . During HUS, there is evidence for increased expression of monocyte-recruiting chemokines [5, 17, 18] and upregulation of their receptors has been observed [19, 20] . We found an increased expression of the chemokines CCL2, CCL3, CCL4 and CCL5 during HUS. We also found that the expression of these chemokines in the kidney coincided with the detection of Gr1 high monocytes. The presence of this monocyte subset is mainly regulated by CCR2, the receptor that binds some of the aforementioned chemokines by a mechanism that enables the emigration of Gr1 high monocytes from the bone marrow [16, 32, 33] . We found that an impaired abundance of Gr1 high monocytes in Ccr2-deficient animals reduce Stx-induced kidney damage and improved the survival. The presence of Gr1 high monocytes has previously been associated with inflammation, tissue injury and reduced functionality of the kidney [12, 25] . Moreover, Gr1 high monocytes are efficient producers of inflammatory molecules that might contribute to the kidney injury and the development of HUS. As the kidney injury marker NGAL and BUN were strongly decreased in Ccr2-deficient animals, Gr1 high monocytes seemed to be directly involved in kidney damage during HUS. Microscopy revealed the presence of Gr1 high monocytes in the kidney cortex, which harbors the main functional units within the kidney, the glomeruli. We also detected an increased uptake of the tracer [ 64 Cu]NOTA-GPVI-Fc within the kidney cortex by PET-MR imaging suggesting that Gr1 high monocytes within the renal glomeruli are directly involved in the glomerular damage and increased BUN levels. Gr1 high monocytes highly expressed the integrin CD11b, which indicates cellular activation and binding to the adhesion molecule ICAM-1 expressed on endothelial cells. Indeed, ICAM-1 was previously shown to be upregulated on endothelial cells after stimulation with Stx [34] . Notably, antibodies against CD11b are potent therapeutic agents in various diseases and targeting this integrin might serve as a potential therapy against HUS [35] [36] [37] . However, depletion of CD11b + cells in CD11c DTR mice showed contrary results in the model of renal IRI [38, 39] . Moreover, depletion of these cells by clodronate-liposomes ameliorated renal damage [39] . These differential results might partially be explained by the efficacy of the depletion and the different myeloid cell types that are targeted by these approaches. These caveats have to be taken into consideration when analyzing the role of CD11b + cells during HUS in a future study.
During HUS, activated Gr1 high monocytes may also exacerbate vascular damage in the glomerulus by producing proinflammatory molecules, such as TNF, which stimulate Gb3 synthesis and thereby leading to sensitization of endothelial cells to shiga toxin [40, 41] . We found reduced levels of the proinflammatory mediators IL-1b and IL-6 in mice deficient for CCR2 indicating that Gr1 high monocytes contribute to the inflammatory response during HUS. Conclusively, this study demonstrates the crucial role of CCR2-dependent Gr1 high monocytes during HUS. Targeting the recruitment of these cells to the kidney might serve as a therapy to reduce the kidney damage during HUS. 
Materials and methods
Mice
All mice were used between 7 and 14 weeks of age and backcrossed to a C57BL/6 background. Mice were bred and maintained under SPF conditions at the animal facilities of the University Clinic Essen and Bonn. Ccr2 −/− [42] mice were used to investigate the role of CCR2 during HUS. Cx 3 cr1 GFP/ + [43] mice were employed to determine the expression of the fractalkine receptor on monocytes and macrophages. Governmental review boards (Bezirksregierung Köln, Landesamt für Natur, Umwelt und Verbraucherschutz NRW in Recklinghausen, Germany) approved the mouse experiments.
Mouse model
The shiga toxin 2 (Stx)(Toxin Technology) dose were determined by a lethal challenge experiment by injecting serial dilutions of Stx in combination with a sublethal dose of LPS (56.25ng/g mouse; Invivogen) in PBS intravenously into mice. The Stx dose that induces 100% mortality between 96 and 120 h (approximately 0.075 ng/g) was selected for the experiments.
Isolation of murine renal leukocytes
Renal leukocytes were isolated by cutting the kidneys into small pieces and digesting with 1 mg/mL collagenase and 0.1 mg/mL DNAse-I (both from Sigma-Aldrich) in RPMI containing 10% FCS and 0.1% sodium azide. After an incubation period of 20 min at 37°C, kidneys were mashed with a syringe plunger and again incubated for 20 min at 37°C. Samples were homogenized by vigorously pipetting using 1000 µL tips and the supernatants were passed through a 100 µm nylon mesh.
BrdU incorporation assay
For in vivo labelling of proliferative cells, mice were intraperitoneally injected with 100 µL BrdU solution (10 mg/mL solution of BrdU in sterile 1× DPBS) 1 day prior analysis. At the time points indicated, mice were sacrificed, kidneys were isolated and renal digests were processed for BrdU staining using the FITC BrdU Flow Kit by BD Biosciences according to the manufacturer´s protocol. 
Flow cytometry
Serum analysis
Blood of Stx/LPS-injected mice was obtained by cardiac puncture of the right heart chamber with a heparinized syringe containing 2 µL Heparin (5000 U/mL, Ratiopharm) in 28 µL PBS. The blood was centrifuged at 16 000 × g for 10 min at 4°C to measure the BUN levels in the plasma.
KIM-1 expression by RT-PCR
Whole-tissue RNA from kidneys was extracted using NucleoSpin RNA plus kit (Macherey-Nagel), according to the manufacturer's instructions. RNA was reverse transcribed into cDNA using QuantiTect Reverse Transcription Kit (Qiagen). Quantitative PCR was performed for 40 cycles using QuantiFast SYBR Green PCR Kit (Qiagen). To detect mouse gene expression of KIM-1 following primers were used (Mm havcr1 fwd:
. All samples were measured in duplicates and normalized to hprt primers (fwd: 5 ′ -GTCCCAGCGTC GTGATTAGCGAT-3 ′ ; rev: 5-GGGCCACAATGTGATGGCCTCC-3 ′ ).
Adoptive transfer of CD45.1 + Gr1 high monocytes
To adoptively transfer bone-marrow-derived Gr1 high monocytes, bone marrow cells from tibia and femur of CD45.1 donor mice were isolated. Then, a two-step MACS isolation procedure was established: first, monocytes were negatively selected from the cell suspension using the Monocyte Isolation Kit (Miltenyi Biotec). 
Chemokine/cytokine analysis
In the supernatant of mechanically homogenized murine kidneys the protein levels of chemokines were determined by using the flow-cytometry based beads assay LEGENDplex 
In vivo PET Imaging
High-resolution non-invasive in vivo PET images were acquired using two small animal Inveon microPET scanners (Siemens Medical Solutions USA, Inc., Knoxville, TN, USA) with a transaxial field of view (FOV) of 10 cm, and an axial FOV of 12.7 cm and a spatial resolution of 1.5 mm in the reconstructed PET images.
Mice were anesthetized with 1.5% isoflurane-O2 (1.5 l/min, 1.5% isoflurane, Abbott GmbH, Wiesbaden, Germany) and injected intravenously with 9.5 ± 0.9 MBq [
64 Cu]NOTA-GPVI-Fc tracer 24 h after Stx/LPS injection. Static PET acquisitions were performed under isoflurane anesthesia, after an uptake time of 60 min, 24 h and 48 h after tracer injection. During PET scans, mice were placed on a heating mat (37°C) to maintain body temperature.
For reconstruction of the PET images, list mode data were processed applying the statistical iterative ordered subset expectation maximization (OSEM) 2D algorithm.
All data were corrected for decay and normalized for each animal to the injected activity. Data were analyzed by drawing regions of interests around the whole left kidney of each mouse. The right kidney was not analyzed to exclude false positive values caused by spillover effects from the unspecific signal in the liver. Image analysis was performed with the Pmod Software (PMOD Technologies Ltd., Zurich, Switzerland).
In vivo MR Imaging
MRI was performed using a 7 T small-animal scanner (Biospec, Bruker Biospin MRI GmbH, Ettlingen, Germany). All mice were anesthetized with 1.5 vol% isoflurane and placed within the scanner's FOV. Imaging was performed using a 3D TurboRARE (TE/TR 58/1800 ms) sequence.
Ex vivo autoradiography
To perform autoradiography, animals were injected with 9.5 ± 0.9 MBq [
64 Cu]NOTA-GPVI-Fc tracer 24 h after Stx/LPS injection. A total of 72 h after Stx/LPS injection, mice were sacrificed and kidneys were removed and embedded in a cutting compound (TissueTek; Sakura Finetek, Torrance, CA, USA). Autoradiography was performed on 20 µm kidney slices with a Storage Phosphor Screen (Molecular Dynamics, Sunnyvale, CA, USA). After an exposure time of 24 h, the phosphor screen was scanned at a resolution of 50 µm/pixel with a STORM Phosphor-Imager (Molecular Dynamics).
Immunohistochemistry
A total of 10 min before sacrificing the mice 2 µg of the Gr-1 antibody (PE, RB6-8C5, BD Bioscience) were injected intravenously.
Kidneys were isolated 24 h after Stx/LPS injection and fixed with 0.05 M phosphate buffer containing 0.1 M L-lysine (pH 7.4, Roth), 2 mg/mL NaIO4 (Roth), and 10 mg/mL paraformaldehyde (Sigma-Aldrich) overnight at 4°C. Kidneys were equilibrated in 30% sucrose (Roth) solution for 24h. Tissues were then frozen in OCT (Weckert Labortechnik) and stored at −80°C. Consecutive sections (10 µm) were mounted on Super Frost Plus glass slides (R.Langenbrinck), dried for 10 min at 70°C, rehydrated with PBS with 0.05% Triton X-100 (Roth) and blocked for 1 h with PBS containing 1% bovine serum albumin (GE Healthcare) and 0.05% Triton X-100. The staining was performed in blocking buffer (200 µL volume per section). The F4/80 antibody (APC, BM8.1, Tonbo bioscience, dilution of 1:100) was incubated for 1 h, DAPI (2 mg/mL, Life Technologies, diluted 1:5000) was incubated for 5 min. After each staining step, three washing steps of 5 min with 0.05% Triton X-100 in PBS were performed. Sections were imaged by the Zeiss Axio Observer.Z1 and Apotome (Zeiss) at the Imaging Center Essen and analysed by the ZEN Software (Zeiss) and FIJI.
To determine NGAL, mice were sacrificed, renal tissue were dissected, fixed in 4% paraformaldehyde (PFA) and embedded in paraffin. Sections (2 µm) were cut and stained for NGAL (rat anti-mouse, Dianova, dilution of 1:1000) to detect tubular damage. Trypsin digest for 15 min at 37°C or by incubation in citrate buffer in the microwave (15 min at 600 Watt) was used for antigen retrieval. After incubation with primary antibodies for 60 min at room temperature in the dark Alexa Fluor conjugated secondary antibodies (488) were incubated for additional 60 min. Analysis was performed in a blinded manner using a Leica imaging microscope. To assess tubular damage, the percentage of tubuli with NGAL expression was estimated in ten different view fields of the cortex in 200-fold magnification.
Total kidney images were generated by the Keyence microscope software with stack function. All images were captured with the same window size.
Statistical analysis
Appropriate assumptions of data (normal distribution or similar variation between experimental groups) were examined before statistical tests were conducted. The sample size was analyzed by G*Power analysis to ensure adequate power to detect a prespecified effect size. The numbers of mice per group are given in the Figure legends. Comparisons were made using non-parametric Mann-Whitney or two-tailed t-test. Comparison of survival curves was performed using a Log-rank (Mantel-Cox) test. Results are expressed as mean ± SEM, *p < 0.05; **p < 0.01; ***p < 0.001.
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